business #ai 📝 BlogAnalyzed: Feb 2, 2026 18:18

Biorce Secures $52.5M to Accelerate Clinical Trials with AI

Published:Feb 2, 2026 17:45

•

1 min read

Analysis

Biorce's innovative use of AI promises to revolutionize the clinical trial process, potentially leading to faster drug development and improved patient outcomes. This significant funding round signals strong investor confidence in the company's vision and technological capabilities, paving the way for further advancements in the field of AI-driven healthcare solutions.

Key Takeaways

•Biorce is using AI to make clinical trials faster.
•The company is based in Barcelona.
•They raised a $52.5M Series A round.

Reference / Citation

View Original

"Barcelona-based Biorce, which is developing an AI service to speed up clinical trials, raised a $52.5M Series A, bringing its total funding to $60M+"

TechmemeFeb 2, 2026 17:45

* Cited for critical analysis under Article 32.

Older

Google AI's Conservation Mission: Preserving Endangered Species' Genetic Secrets

Newer

OpenAI Prism: Turning Practical Notes into Surprisingly Readable Research